translate page

Novartis' breast cancer treatment wins FDA approval

The U.S. Food and Drug Administration (FDA) said on Friday that it had approved Novartis AG's treatment in combination with a hormone therapy for postmenopausal women, as well as for men, with a form of advanced breast cancer.


from Reuters: Health News https://reut.rs/2MhNBcm

Post a Comment

1 Comments

  1. It's a good news that Novartis' breast cancer treatment wins FDA approval. FDA Establishment Registration

    ReplyDelete